Since KRAS and BRAF gene mutations are frequently present in colon cancers and have adverse prognostic significance, we examined whether mutations in these genes were more prevalent in tumors with high STAT1 expression, which could have contributed to poor prognosis. The gene discussed is STAT1; the disease is colonic neoplasm.